Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 103,203 $ 79,223
Short-term investments 313,812 86,873
Restricted cash - short-term 194 194
Prepaid expenses and other current assets 7,861 5,900
Total current assets 425,070 172,190
Property and equipment, net 66,075 44,129
Restricted cash - long-term 1,200 1,200
Other assets 362 260
Total assets 492,707 217,779
Current liabilities:    
Accounts payable 6,545 14,711
Accrued compensation 5,276 5,664
Accrued research and development expenses 6,661 4,006
Other current liabilities 8,752 3,265
Total current liabilities 27,234 27,646
Long-term liabilities 12,974 12,269
Total liabilities 40,208 39,915
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Common stock—$0.0001 par value, 500,000 shares authorized as of June 30, 2018 and December 31, 2017; 45,334 and 30,730 shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively 5 3
Additional paid-in capital 841,975 474,662
Accumulated other comprehensive loss (505) (151)
Accumulated deficit (388,976) (296,650)
Total stockholders’ equity 452,499 177,864
Total liabilities and stockholders’ equity $ 492,707 $ 217,779